Avignon - September 27, 2010. Naturex, global leader in specialty plant-based natural ingredients, has presented its development forecasts and strategy to the financial community.
Driven by strong and consistent growth on the natural ingredients market and by its new size since the beginning of the year following its acquisition of the Ingredients division of Natraceutical, the group's current business dynamic looks set to stay.
After an excellent first half (sales growth of close to 15% and a like-for-like improvement of over 2 points in its operating margin), Naturex's outlook for 2010 is positive. At constant scope and in constant currencies, sales were up 16.5% at the end of August.
As a result, Naturex is raising its financial objectives for 2010. Today, the group is targeting sales growth of 10% to 15% at constant scope and in constant currencies (5% to 10% previously), and a 2.5 to 3 point increase in its operating margin on the proforma figure for 2009 (9% of revenue).
Moreover, galvanized by the successful integration of the Ingredients division of Natraceutical in record time, Naturex is looking into new acquisition opportunities.
Naturex will publish its revenues for the third quarter of 2010 on Tuesday 19 October after the close of trading.
If you would like to receive financial information about Naturex by e-mail, go to: www.actusnews.com
NATUREX has been listed on segment B of Euronext Paris since October 1996.
Number of shares: 6,387,192 (4,866,789 ordinary shares and 1,520,403 preferential shares).
ISIN: FR0000054694 - Reuters: NATU.PA - Bloomberg: NRX:FP.
Naturex is the global leader in specialty plant-based natural ingredients. The company produces and markets natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries. The group has three strategic divisions: Food & Beverage, Nutrition & Health and Personal Care.
Naturex's sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers with the means to meet the requirements of their end consumers. Its strength lies in its ability to position itself on specific products which constitute market niches.
Based in Avignon, the group employs around 900 people and realizes over 90% of its sales overseas. Naturex has production units across Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also has 15 sales offices located in Europe, the United States and Asia.
Jacques Dikansky, President and CEO, Tel. +33 (0)4 90 23 96 89, firstname.lastname@example.org
Thierry Lambert, Vice-President and CFO, Tel. +33 (0)4 90 23 96 89, email@example.com
Laurence Marquézy, Investor Relations, Tel. + 33 (0)1 72 74 82 23, firstname.lastname@example.org
Anne Catherine Bonjour, Press Relations, Tel. + 33 (0)1 53 67 36 93, email@example.comInformation réglementée
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-21247-naturex27092010-en-cp.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
|NATUREX||Euronext Paris||83.62||0.14%||3 577|